A U.S.-based biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, in particular diseases caused primarily by exposure to sunlight that result in sun damage to the skin. Our licensed products focus on the treatment of actinic keratoses which are skin lesions that can sometimes lead to skin cancer.
Lead Underwriter
Roth Capital Partners, Inc, The Benchmark Company, LLC
